Phospho-ablation of cardiac sodium channel Nav1.5 mitigates susceptibility to atrial fibrillation and improves glucose homeostasis under conditions of diet-induced obesity

Int J Obes (Lond). 2021 Apr;45(4):795-807. doi: 10.1038/s41366-021-00742-4. Epub 2021 Jan 26.

Abstract

Background: Atrial fibrillation (AF) is the most common sustained arrhythmia, with growing evidence identifying obesity as an important risk factor for the development of AF. Although defective atrial myocyte excitability due to stress-induced remodeling of ion channels is commonly observed in the setting of AF, little is known about the mechanistic link between obesity and AF. Recent studies have identified increased cardiac late sodium current (INa,L) downstream of calmodulin-dependent kinase II (CaMKII) activation as an important driver of AF susceptibility.

Methods: Here, we investigated a possible role for CaMKII-dependent INa,L in obesity-induced AF using wild-type (WT) and whole-body knock-in mice that ablates phosphorylation of the Nav1.5 sodium channel and prevents augmentation of the late sodium current (S571A; SA mice).

Results: A high-fat diet (HFD) increased susceptibility to arrhythmias in WT mice, while SA mice were protected from this effect. Unexpectedly, SA mice had improved glucose homeostasis and decreased body weight compared to WT mice. However, SA mice also had reduced food consumption compared to WT mice. Controlling for food consumption through pair feeding of WT and SA mice abrogated differences in weight gain and AF inducibility, but not atrial fibrosis, premature atrial contractions or metabolic capacity.

Conclusions: These data demonstrate a novel role for CaMKII-dependent regulation of Nav1.5 in mediating susceptibility to arrhythmias and whole-body metabolism under conditions of diet-induced obesity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atrial Fibrillation / prevention & control*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Diet, High-Fat / adverse effects
  • Gene Knock-In Techniques
  • Glucose / metabolism
  • Homeostasis
  • Male
  • Mexiletine / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • NAV1.5 Voltage-Gated Sodium Channel / genetics
  • NAV1.5 Voltage-Gated Sodium Channel / metabolism*
  • Obesity / physiopathology*
  • Phosphorylation

Substances

  • NAV1.5 Voltage-Gated Sodium Channel
  • Scn5a protein, mouse
  • Mexiletine
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Glucose